189 related articles for article (PubMed ID: 20870569)
1. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community.
Seals R; Bartell SM; Steenland K
Environ Health Perspect; 2011 Jan; 119(1):119-24. PubMed ID: 20870569
[TBL] [Abstract][Full Text] [Related]
2. Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility.
Hoffman K; Webster TF; Bartell SM; Weisskopf MG; Fletcher T; Vieira VM
Environ Health Perspect; 2011 Jan; 119(1):92-7. PubMed ID: 20920951
[TBL] [Abstract][Full Text] [Related]
3. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.
Bartell SM; Calafat AM; Lyu C; Kato K; Ryan PB; Steenland K
Environ Health Perspect; 2010 Feb; 118(2):222-8. PubMed ID: 20123620
[TBL] [Abstract][Full Text] [Related]
4. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources.
Emmett EA; Shofer FS; Zhang H; Freeman D; Desai C; Shaw LM
J Occup Environ Med; 2006 Aug; 48(8):759-70. PubMed ID: 16902368
[TBL] [Abstract][Full Text] [Related]
5. Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure.
Barry V; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2014 Jul; 132():62-9. PubMed ID: 24742729
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley.
Steenland K; Zhao L; Winquist A; Parks C
Environ Health Perspect; 2013 Aug; 121(8):900-5. PubMed ID: 23735465
[TBL] [Abstract][Full Text] [Related]
7. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project.
Shin HM; Vieira VM; Ryan PB; Steenland K; Bartell SM
Environ Health Perspect; 2011 Dec; 119(12):1760-5. PubMed ID: 21813367
[TBL] [Abstract][Full Text] [Related]
8. Polyfluoroalkyl substance exposure in the Mid-Ohio River Valley, 1991-2012.
Herrick RL; Buckholz J; Biro FM; Calafat AM; Ye X; Xie C; Pinney SM
Environ Pollut; 2017 Sep; 228():50-60. PubMed ID: 28505513
[TBL] [Abstract][Full Text] [Related]
9. Predictors of PFOA levels in a community surrounding a chemical plant.
Steenland K; Jin C; MacNeil J; Lally C; Ducatman A; Vieira V; Fletcher T
Environ Health Perspect; 2009 Jul; 117(7):1083-8. PubMed ID: 19654917
[TBL] [Abstract][Full Text] [Related]
10. Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant.
Barry V; Winquist A; Steenland K
Environ Health Perspect; 2013; 121(11-12):1313-8. PubMed ID: 24007715
[TBL] [Abstract][Full Text] [Related]
11. A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes.
Dhingra R; Winquist A; Darrow LA; Klein M; Steenland K
Environ Health Perspect; 2017 Mar; 125(3):416-421. PubMed ID: 27529882
[TBL] [Abstract][Full Text] [Related]
12. A measure of community exposure: PFOA in well water correlates with serum levels.
Betts KS
Environ Health Perspect; 2011 Jan; 119(1):A35. PubMed ID: 21196148
[No Abstract] [Full Text] [Related]
13. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers.
Winquist A; Lally C; Shin HM; Steenland K
Environ Health Perspect; 2013 Aug; 121(8):893-9. PubMed ID: 23735518
[TBL] [Abstract][Full Text] [Related]
14. Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort.
Dhingra R; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Apr; 146():323-30. PubMed ID: 26802619
[TBL] [Abstract][Full Text] [Related]
15. Serum PFOA levels in residents of communities near a Teflon-production facility.
Karstadt ML
Environ Health Perspect; 2007 Oct; 115(10):A486-7. PubMed ID: 17938708
[No Abstract] [Full Text] [Related]
16. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community.
Dhingra R; Lally C; Darrow LA; Klein M; Winquist A; Steenland K
Environ Res; 2016 Feb; 145():85-92. PubMed ID: 26656498
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic and behavioral determinants of serum concentrations of per- and polyfluoroalkyl substances in a community highly exposed to aqueous film-forming foam contaminants in drinking water.
Barton KE; Starling AP; Higgins CP; McDonough CA; Calafat AM; Adgate JL
Int J Hyg Environ Health; 2020 Jan; 223(1):256-266. PubMed ID: 31444118
[TBL] [Abstract][Full Text] [Related]
18. Human biomonitoring follow-up study on PFOA contamination and investigation of possible influencing factors on PFOA exposure in a German population originally exposed to emissions from a fluoropolymer production plant.
Lahne H; Gerstner D; Völkel W; Schober W; Aschenbrenner B; Herr C; Heinze S; Quartucci C
Int J Hyg Environ Health; 2024 Jun; 259():114387. PubMed ID: 38703464
[TBL] [Abstract][Full Text] [Related]
19. Per- and polyfluoroalkyl substance (PFAS) exposure assessment in a community exposed to contaminated drinking water, New Hampshire, 2015.
Daly ER; Chan BP; Talbot EA; Nassif J; Bean C; Cavallo SJ; Metcalf E; Simone K; Woolf AD
Int J Hyg Environ Health; 2018 Apr; 221(3):569-577. PubMed ID: 29514764
[TBL] [Abstract][Full Text] [Related]
20. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community.
Savitz DA; Stein CR; Bartell SM; Elston B; Gong J; Shin HM; Wellenius GA
Epidemiology; 2012 May; 23(3):386-92. PubMed ID: 22370857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
